NANOrdica
Estonia
NANOrdica
New nano-based antibacterial products for wound care
Supported : 405 €
of 250 € minimum goal
Pitch
Due to the increasing prevalence of bacterial infections, resistance of bacteria to antibiotics and population aging, there is a great world-wide need for the new antibacterial agents. Silver is the most known but rather toxic agent in antibacterial wound-care products. Nanordica Medical provides new nano-based products that have good antibacterial properties and are less toxic to human cells and to the environment than silver.